High Molecular Weight Fucoidan Restores Intestinal Integrity by Regulating Inflammation and Tight Junction Loss Induced by Methylglyoxal-Derived Hydroimidazolone-1
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, Jae-Min | - |
dc.contributor.author | Yoo, Hee Joon | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.date.accessioned | 2022-11-18T17:40:24Z | - |
dc.date.available | 2022-11-18T17:40:24Z | - |
dc.date.created | 2022-11-17 | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 1660-3397 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145780 | - |
dc.description.abstract | Fucoidan from brown seaweeds has several biological effects, including preserving intestinal integrity. To investigate the intestinal protective properties of high molecular weight fucoidan (HMWF) from Undaria pinnatifida on intestinal integrity dysfunction caused by methylglyoxal-derived hydroimidazolone-1 (MG-H1), one of the dietary advanced-glycation end products (dAGEs) in the human-colon carcinoma-cell line (Caco-2) cells and ICR mice. According to research, dAGEs may damage the intestinal barrier by increasing gut permeability. The findings of the study showed that HMWF + MG-H1 treatment reduced by 16.8% the amount of reactive oxygen species generated by MG-H1 treatment alone. Furthermore, HMWF + MGH-1 treatment reduced MG-H1-induced monolayer integrity disruption, as measured by alterations in transepithelial electrical resistance (135% vs. 75.5%) and fluorescein isothiocyanate incorporation (1.40 x 10(-6) cm/s vs. 3.80 cm/s). HMWF treatment prevented the MG-H1-induced expression of tight junction markers, including zonula occludens-1, occludin, and claudin-1 in Caco-2 cells and mouse colon tissues at the mRNA and protein level. Also, in Caco-2 and MG-H1-treated mice, HMWF plays an important role in preventing receptor for AGEs (RAGE)-mediated intestinal damage. In addition, HMWF inhibited the nuclear factor kappa B activation and its target genes leading to intestinal inflammation. These findings suggest that HMWF with price competitiveness could play an important role in preventing AGEs-induced intestinal barrier dysfunction. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | GLYCATION END-PRODUCTS | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | BARRIER DYSFUNCTION | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | GUT MICROBIOTA | - |
dc.subject | IN-VITRO | - |
dc.subject | DIET | - |
dc.subject | INHIBITION | - |
dc.subject | EXPRESSION | - |
dc.subject | GLYCOTOXINS | - |
dc.title | High Molecular Weight Fucoidan Restores Intestinal Integrity by Regulating Inflammation and Tight Junction Loss Induced by Methylglyoxal-Derived Hydroimidazolone-1 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.identifier.doi | 10.3390/md20090580 | - |
dc.identifier.scopusid | 2-s2.0-85138459874 | - |
dc.identifier.wosid | 000856625600001 | - |
dc.identifier.bibliographicCitation | MARINE DRUGS, v.20, no.9 | - |
dc.relation.isPartOf | MARINE DRUGS | - |
dc.citation.title | MARINE DRUGS | - |
dc.citation.volume | 20 | - |
dc.citation.number | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | GLYCATION END-PRODUCTS | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | BARRIER DYSFUNCTION | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | GUT MICROBIOTA | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | DIET | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GLYCOTOXINS | - |
dc.subject.keywordAuthor | fucoidan | - |
dc.subject.keywordAuthor | intestinal barrier | - |
dc.subject.keywordAuthor | advanced glycation end product | - |
dc.subject.keywordAuthor | methylglyoxal-derived hydroimidazolone-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.